Wali Razaz, Alhindi Hayat, Saber Arwa, Algethami Khowlah, Alhumaidah Reem
Family Medicine, King Abdulaziz Medical City, National Guard Hospital, Jeddah, SAU.
Family Medicine, King Saud Bin Abdulaziz University for Health Sciences College of Medicine, Jeddah, SAU.
Cureus. 2023 Jun 7;15(6):e40076. doi: 10.7759/cureus.40076. eCollection 2023 Jun.
The coronavirus disease 2019 (COVID-19) vaccine was developed to stimulate acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms of reproductive health abnormalities have been reported following the administration of the adenovirus and mRNA-containing vaccine. Such complaints included irregular menstrual cycles, miscarriages, changes in sexual interest, vaginal bleeding, and decreased milk supply in breastfeeding mothers. This study aimed to explore the effect of the COVID-19 vaccine on the reproductive health of women attending five primary healthcare centers in the western region of Saudi Arabia.
A cross-sectional study was conducted with 300 women between 15 and 50 years. Five primary healthcare centers were included from May to September 2022. Non-probability convenient sampling technique was used; data were collected via a self-administered questionnaire from women who received any number or type of COVID-19 vaccine. Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 22 (IBM SPSS Statistics, Armonk, NY, USA).
Of those who responded to the questionnaire (297 participants), 74% were married, and 52% had 1-3 children. Of the pregnant women, only 4% lost their pregnancy. In addition, of the breastfeeding mothers, 10% noticed a decrease in milk production after the vaccination. The effect of the vaccination status on decreased libido was 11%. A small proportion (18%) of the participants reported worsening dietary habits after the vaccine. Less than half of the participants (44%) reported a change in the length and amount of the menstrual cycle, and 29% worsened premenstrual syndrome (PMS). There was no significant association between the type and the number of doses on the rate of miscarriage (p=0.47), breastmilk production (p=0.47), libido (p=0.11), health diet habits (p=0.15), monthly cycle (p=0.570), heavy menses (p=0.999), and PMS symptoms in the study participants.
COVID-19 vaccination remains necessary to prevent severe infection and is safe for females of reproductive age, whether trying to get pregnant or lactating, and has no significant effect on the menstrual cycle. This research can be used as a basis when deciding on vaccines in case of future pandemics and remove misinformation and doubts regarding the vaccines that should be adequately addressed.
2019年冠状病毒病(COVID-19)疫苗的研发目的是激发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的获得性免疫力。在接种腺病毒疫苗和含信使核糖核酸(mRNA)疫苗后,有生殖健康异常症状的报告。这些症状包括月经周期不规律、流产、性兴趣改变、阴道出血以及哺乳期母亲乳汁分泌减少。本研究旨在探讨COVID-19疫苗对沙特阿拉伯西部地区五个初级医疗保健中心女性生殖健康的影响。
对300名年龄在15至50岁之间的女性进行了一项横断面研究。纳入了2022年5月至9月期间的五个初级医疗保健中心。采用非概率方便抽样技术;通过自填问卷收集接受过任何数量或类型COVID-19疫苗接种的女性的数据。使用社会科学统计软件包(SPSS)22版(IBM SPSS Statistics,美国纽约州阿蒙克)进行数据分析。
在对问卷做出回应的人中(297名参与者),74%已婚,52%育有1至3个孩子。在孕妇中,只有4%发生流产。此外,在哺乳期母亲中,10%注意到接种疫苗后乳汁分泌减少。接种状态对性欲减退的影响为11%。一小部分参与者(18%)报告接种疫苗后饮食习惯变差。不到一半的参与者(44%)报告月经周期的长度和量发生了变化,29%的人经前综合征(PMS)加重。在研究参与者中,疫苗类型和剂量数量与流产率(p=0.47)、母乳分泌(p=0.47)、性欲(p=0.11)、健康饮食习惯(p=0.15)、月经周期(p=0.570)、月经过多(p=0.999)和PMS症状之间没有显著关联。
接种COVID-19疫苗对于预防严重感染仍然是必要的,对育龄女性来说是安全的,无论她们是正在备孕还是处于哺乳期,并且对月经周期没有显著影响。在未来大流行情况下决定是否接种疫苗时,本研究可作为参考依据,消除关于疫苗的错误信息和疑虑,这些问题应得到充分解决。